Haematopoietic stem cells (HSCs) are the founder cells of the adult haematopoietic system, and thus knowledge of the molecular program directing their generation during development is important for regenerative haematopoietic strategies. Runx1 is a pivotal transcription factor required for HSC generation in the vascular regions of the mouse conceptus-the aorta, vitelline and umbilical arteries, yolk sac and placenta 1,2 . It is thought that HSCs emerge from vascular endothelial cells through the formation of intraarterial clusters 3 and that Runx1 functions during the transition from 'haemogenic endothelium' to HSCs 4,5 . Here we show by conditional deletion that Runx1 activity in vascular-endothelial-cadherin-positive endothelial cells is indeed essential for intraarterial cluster, haematopoietic progenitor and HSC formation in mice. In contrast, Runx1 is not required in cells expressing Vav1, one of the first pan-haematopoietic genes expressed in HSCs. Collectively these data show that Runx1 function is essential in endothelial cells for haematopoietic progenitor and HSC formation from the vasculature, but its requirement ends once or before Vav is expressed.
Haematopoietic stem cells (HSCs) are the founder cells of the adult haematopoietic system, and thus knowledge of the molecular program directing their generation during development is important for regenerative haematopoietic strategies. Runx1 is a pivotal transcription factor required for HSC generation in the vascular regions of the mouse conceptus-the aorta, vitelline and umbilical arteries, yolk sac and placenta 1, 2 . It is thought that HSCs emerge from vascular endothelial cells through the formation of intraarterial clusters 3 and that Runx1 functions during the transition from 'haemogenic endothelium' to HSCs 4, 5 . Here we show by conditional deletion that Runx1 activity in vascular-endothelial-cadherin-positive endothelial cells is indeed essential for intraarterial cluster, haematopoietic progenitor and HSC formation in mice. In contrast, Runx1 is not required in cells expressing Vav1, one of the first pan-haematopoietic genes expressed in HSCs. Collectively these data show that Runx1 function is essential in endothelial cells for haematopoietic progenitor and HSC formation from the vasculature, but its requirement ends once or before Vav is expressed.
HSCs are found in several independent sites in the conceptus, and the transcription factor Runx1, which is required for HSC generation, is expressed in these sites 4 . Runx1 protein is seen in the mesodermal masses and endoderm of the prospective yolk sac blood islands at the neural plate stage 4, 6 , in the mesoderm of the distal allantois and chorion (precursors of the placenta) at headfold stages 7 , and in endothelial cells in the distal allantois, dorsal aorta, and vitelline and umbilical arteries starting the 4-6 somite pair stage (data not shown). Runx1 is expressed at 9.5-10.5 days post coitus (d.p.c.) in both endothelial and mesenchymal cells in the dorsal aorta and placental labyrinth 4, 7, 8 . Therefore it is not clear whether Runx1 is required in mesoderm, endoderm, mesenchyme and/or endothelial cells for intra-arterial cluster and HSC formation.
To examine the hypothesis that Runx1 is required in endothelial cells per se, we deleted Runx1 in vascular endothelial cadherin (VEC)positive cells. VEC is a transmembrane protein located at cell-to-cell adherens junctions that is involved in endothelial cell adhesion 9 . VEC is expressed transiently in the yolk sac mesoderm at 7.5 d.p.c.; however, at 8.5 d.p.c. its expression is highly restricted to endothelial cells in the dorsal aorta and heart [10] [11] [12] . At 9.5 d.p.c. VEC is expressed in vasculature throughout the conceptus 11 . Distinct mesodermal populations give rise to the yolk sac blood islands and to the major arteries of the conceptus, including those in the placenta [13] [14] [15] . Thus, with Cre recombinase expressed from VEC (Cdh5) regulatory sequences (VEC-Cre) we could monitor the impact of Runx1 excision on HSC formation from the vasculature including the dorsal aorta, vitelline and umbilical arteries, and placenta-sites where VEC expression initiates in endothelium.
We generated a VEC-Cre transgene ( Fig. 1a ) and used Cre-reporter mice (R26R-lacZ and R26R-YFP) to characterize its activity. The first sites of VEC-Cre activity were in the yolk sac and chorionic mesoderm (not shown). Primitive erythrocytes in the yolk sac blood islands were b-galactosidase 1 (b-gal 1 ), as were Pecam1 1 cells in the vitelline vasculature ( Fig. 1b ). By 9.5 d.p.c. b-gal activity was high in vasculature throughout the conceptus ( Fig. 1c ), particularly within Pecam1 1 cells in the developing labyrinth of the placenta and in the umbilical artery ( Fig. 1d ). At 10.5 d.p.c. b-gal 1 endothelial cells and intra-arterial clusters were present in the dorsal aorta and vitelline and umbilical arteries, whereas mesenchymal cells were b-gal 2 (Fig. 1f ). VEC-Cre-mediated excision occurred in 77% (611%) of cell surface Sca1 2 (also known as Ly-6A/E and Ly-6a) VEC 1 endothelial cells in the aorta-gonad-mesonephros (AGM) region plus vitelline and umbilical arteries of 11.5-d.p.c. conceptuses and in 86% of Sca1 1 VEC 1 cells ( Fig. 1e ; Sca1 marks 50% of HSCs, and VEC marks all HSCs in the AGM region) 2, 16 . No excision was detectable in Sca1 1 VEC 2 cells ( Fig. 1e ). There was widespread VEC-Cre activity in the fetal liver ( Fig. 1f , g), 99% of which was localized to CD45 1 (encoded by Ptprc), CD71 1 (also known as Tfrc 1 ) and/or Ter119 1 (Ly76 1 ) blood cells (not shown). Approximately 85% of fetal liver blood cells in 15.5-d.p.c. R26R-YFP;VEC-Cre fetuses were YFP 1 (Fig. 1h ), and are consequently derived from cells that at one time in their history expressed VEC. Ninety-six per cent of CD45 1 adult bone marrow cells were YFP 1 (Fig. 1i ), and thus almost all adult blood is derived from VEC-expressing cells.
VEC-Cre-mediated deletion in mice homozygous for floxed Runx1 alleles (Runx1 f/f ) caused a 65% rate of fetal lethality ( Supplementary  Table 1 ), and approximately 10% of 12.5-d.p.c. Runx1 f/f ;VEC-Cre fetuses had central nervous system haemorrhaging and fetal liver anaemia characteristic of Runx1 deficiency 17,18 ( Fig. 2a and Supplementary Table 1 ). There was an eightfold decrease in c-kit 1 (also known as Kit) cells in the livers of 11.5-d.p.c. Runx1 f/f ;VEC-Cre fetuses (Fig. 2b) , and in colony-forming unit culture (CFU-C) progenitors in all haematopoietic sites ( Fig. 2c ). DNA analysis revealed that 84% of colonies derived from Runx1 f/1 ;VEC-Cre fetal cells had excised the Runx1 f allele ( Fig. 2d and Supplementary Table 2 ), consistent with the deletion efficiency determined with the R26R-YFP allele. In contrast, only 1 out of 389 colonies picked from cultures established from Runx1 f/f ;VEC-Cre fetuses had two deleted Runx1 f alleles. Thus, at least one functional Runx1 allele must be present in a VEC 1 cell for CFU-C progenitors to emerge in the fetus.
In vivo repopulation assays revealed that haematopoietic tissues of 11.5-d.p.c. Runx1 f/f ;VEC-Cre conceptuses could engraft adult mice, but at a much reduced frequency compared to Runx1 f/1 ;VEC-Cre cells ( Fig. 3a, b ). Whereas all donor-derived CFU-C progenitors in the recipients of Runx1 f/1 ;VEC-Cre HSCs had a deleted Runx1 f allele, both Runx1 f alleles were deleted in only 1 out of 192 colonies generated from Runx1 f/f ;VEC-Cre donor-derived HSCs (Fig. 3c ). We also analysed the bone marrow of viable Runx1 f/f ;VEC-Cre adult mice and found that all colonies retained at least one undeleted Runx1 f allele (Supplementary Table 2 ). Therefore there is strong selective pressure for cells that escape the excision of at least one Runx1 f allele to contribute to haematopoiesis in Runx1 f/f ;VEC-Cre mice. Together, these data indicate that Runx1 is required in VEC 1 cells for HSC formation.
Because the autonomous production of HSCs occurs first in the major arteries of the conceptus at 10.5 d.p.c. (dorsal aorta as well as vitelline and umbilical arteries) 19 , and HSCs localize to the walls of these arteries 2,16 , we examined intra-arterial cluster formation in Runx1 f/f ;VEC-Cre embryos. VEC is expressed on both endothelial cells and intra-arterial clusters, but the first potential site of deletion is in the endothelium that gives rise to the clusters. No haematopoietic clusters were visible in the dorsal aorta and vitelline and umbilical arteries of Runx1 f/f ;VEC-Cre animals, and there was a 90-fold decrease in c-kit hi cells ( Fig. 3d ). Thus, the important deletion event in these arteries occurred in the endothelium.
To confirm this and to determine whether Runx1 continues to be required once the endothelial-cell-to-HSC transition is complete, we examined the outcome of deleting Runx1 using Vav-Cre. Vav1 is a GDP/GTP nucleotide-exchange factor for Rho/Rac, the expression of which is restricted to haematopoietic cells 20, 21 . Vav1 was also implicated as a Runx1 target, because its transcript was not detected in the AGM region or fetal liver of Runx1-deficient embryos 22 . Excision of the R26R-YFP allele by Vav-Cre occurred in 68% (616%) of CD45 1 VEC 2 haematopoietic cells from the AGM region and vitelline and umbilical arteries and not in CD45 2 VEC 1 endothelium ( Fig. 4a ). Excised b-gal 1 cells were not found in intra-arterial clusters at either 10.5 d.p.c. or 11.5 d.p.c., and were instead located within the sub-aortic mesenchyme and the circulation ( Fig. 4b-d ). Therefore Vav-Cre marked cells that either originated in the yolk sac or had upregulated Vav-Cre subsequent to their release from the intra-arterial clusters. b-gal 1 cells were detectable in the fetal liver at 10.5 d.p.c. (not shown), and by 11.5 d.p.c. 63% (613%) of CD45 1 VEC 2 cells in the fetal liver were YFP 1 (Fig. 4a ) and were easily seen by histology ( Fig. 4e ). Fetal liver HSCs transiently express cell-surface VEC 23, 24 . Sixty-three (615) per cent of the CD45 1 VEC lo HSC-containing population in the 11.5-d.p.c. fetal liver was YFP 1 (Fig. 4a ), and by 15.5 d.p.c. 90% of lineage-negative Sca1 1 Mac-1 1 (also known as Itgam 1 ) fetal liver cells were YFP 1 (not shown), similar to the excision frequencies reported previously 21 . Thus, with Vav-Cre we could perform an excision in CD45 1 cells while avoiding deletion in the intra-arterial clusters or endothelium.
In contrast to VEC-Cre, excision of Runx1 with Vav-Cre did not affect fetal or adult viability (Supplementary Table 3 ). The haematopoietic deficiencies described in adult mice upon Runx1 deletion with Mx1-Cre, including thrombocytopenia, defective lymphopoiesis and expansion of the lineage-negative (Lin 2 ) Sca1 1 c-kit 1 (LSK) population 25, 26 , were also apparent in the Runx1 f/f ;Vav-Cre mice ( Supplementary Fig. 2 ). Fetal livers from 15.5-d.p.c. Runx1 f/f ;Vav-Cre mice had increased numbers of CFU-C progenitors, particularly granulocyte/macrophage (GM) and multipotent (GEMM) progenitors ( Fig. 4f) , as was previously observed in the bone marrow of Mx1-Cre deleted adult mice 25, 26 . Thus, deletion of Runx1 in Vav 1 cells did not impair the emergence of CFU-C progenitors but did affect their homeostasis. Importantly, both Runx1 f alleles were deleted in 280 out of 281 colonies from 15.5-d.p.c. Runx1 f/f ;Vav-Cre fetal livers ( Supplementary Table 4 ). Colonies from 11.5-d.p.c. animals contained Runx1 f alleles at various stages of deletion ( Fig. 4g ) because excision is initiating close to that time. Nevertheless, 32% of colonies from the haematopoietic tissues of 11.5-d.p.c. fetuses contained two deleted Runx1 f alleles, and by 14.5 d.p.c. 100% of fetal liver progenitors had deleted both alleles ( Supplementary Table 4 ). We therefore conclude that Runx1 function is no longer required once a CFU-C progenitor expresses Vav.
VEC-pro
Cre-pA Insulator Insulator Mice were efficiently engrafted with haematopoietic tissues from 11.5-d.p.c. Runx1 f/f ;Vav-Cre conceptuses (Fig. 4h) , and, in all colonies (94 out of 94) derived from donor Runx1 f/f ;Vav-Cre HSCs, both Runx1 f alleles were deleted (Supplementary Table 4 ). The same was true in adult Runx1 f/f ;Vav-Cre mice; virtually all CFU-C progenitors had deleted both Runx1 f alleles ( Supplementary Table 4 ). Hence, Runx1 is not required in a Vav 1 HSC.
In summary, the most essential function of Runx1 is during the transition from VEC 1 cells to Vav 1 HSCs, although it continues to provide important activity in maintaining normal HSC function and for the terminal differentiation of some lineages 25, 26 ( Supplementary  Fig. 1 ). Our data demonstrate that the relevant VEC 1 HSC precursors are in the haemogenic endothelium. Although the yolk sac mesoderm expresses VEC, in the placenta, vitelline and umbilical arteries, and dorsal aorta, which are independent haematopoietic sites derived from distinct populations of mesoderm [13] [14] [15] , VEC expression is restricted to intra-arterial clusters and endothelium. Intra-arterial clusters in these sites are absent in Runx1 f/f ;VEC-Cre conceptuses, and therefore the relevant deletion event must have occurred in the endothelium from which they are derived. Continued deletion by VEC-Cre in fetal liver HSCs is unlikely because Runx1 is no longer required once HSCs reach the fetal liver and express Vav, yet they all contain undeleted Runx1 f alleles. We also showed that most adult blood ($95%) is derived from a cell that at one time in its history expressed VEC. Our working model is that most HSCs are born from VEC 1 haemogenic endothelium in the conceptus, although a VEC 1 HSC precursor in adult bone marrow cannot be ruled out. It has been shown 27 that a small but detectable number of bone marrow cells (,0.4%) could be labelled when a tamoxifen-regulated VEC-Cre was activated in the adult, hence VEC 1 adult HSC precursors, if they exist, are rare cells.
Another model for HSC emergence posits that HSCs in the AGM region originate in subaortic patches of cells in the ventral para-aortic mesenchyme of the dorsal aorta 28 , and migrate towards the aorta and between endothelial cells to form the intra-aortic clusters. Because we showed that almost all blood is derived from VEC 1 cells, subaortic patches of cells must upregulate VEC as they protrude through the endothelium.
METHODS SUMMARY
Conditional deletion by VEC-Cre or Vav-Cre. A 2.5 kilobase (kb) VEC (Cdh5) promoter sequence was cloned between insulators from the chicken c-globin gene 29 and used to drive Cre expression. The construct was injected into fertilized oocytes from C57BL6/J 3 129S1/SvImJ F 1 mice. R26R-lacZ/1; VEC-Cre or R26R-YFP/1; VEC-Cre conceptuses were generated by crossing VEC-Cre/1 males with R26R-lacZ/1 or R26R-YFP/1 females. Runx1 f/1 ; VEC-Cre and Runx1 f/f ; VEC-Cre conceptuses were generated by crossing Runx1 f/1 ; VEC-Cre/1 males with Runx1 f/f females. Runx1 f/1 ; R26R-YFP/1; VEC-Cre or Runx1 f/f ; R26R-YFP/1; VEC-Cre conceptuses were generated by crossing Runx1 f/1 ; R26R-YFP/1; VEC-Cre/1 males with Runx1 f/f females. Similar breeding strategies were used for Vav-Cre deletion. Microscopic and histological analyses. Conceptuses were suspended in phosphate-buffered saline or in a 1:2 mixture of benzyl alcohol and benzyl benzoate, and visualized with a stereomicroscope. X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactoside; Sigma) staining was performed as described previously 4 . In some cases the conceptuses were also incubated with rat anti-mouse Pecam1 and ABC reagent at 4 uC 30 , and then treated with DAB peroxidase substrate. Conceptuses were embedded in paraffin, sectioned and counterstained with nuclear fast red.
To analyse intra-aortic clusters, embryos were fixed and stained with anti-ckit and anti-Pecam1-antibodies. A 1:2 mix of benzyl alcohol and benzyl benzoate was used to increase the transparency of tissues. Samples were analysed with a confocal microscope using the multi-track sequential mode. Three-dimensional reconstructions were generated from Z-stacks (62-87 serial sections). Haematopoietic assays. Methylcellulose colony-forming assays were performed as described previously 4 , and colonies counted after 7 days. Fetal tissues were transplanted as described previously 16 .
Immuno-staining was performed with phycoerytherin-, allophycocyanin-or Alexa-Fluor-647-conjugated antibodies. Stained cells were analysed on a Becton Dickinson FACSCalibur flow cytometer. Dead cells were excluded with 7-amino-actinomycin D (7-AAD).
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
